Sign in

Archives of Neuroscience

e-ISSN 2322-5769
p-ISSN 2322-3944
Authors GuideSubmit manuscript
Cover image of the article: Retracted: Investigating the Protective Effect of Ellagic Acid on Cholemic Nephropathy in Cholestatic Rats

Image Credit:Arch Neurosc

Outline

https://doi.org/10.5812/ans-141082

Retracted: Investigating the Protective Effect of Ellagic Acid on Cholemic Nephropathy in Cholestatic Rats

Authors

Ali Kargar1, 2, Fatemeh MohammadiFatemeh Mohammadi ORCID3, Mehran Amirizadeh4, Negin Hallajbashi5, Fatemeh Kargar6, Hamidreza MohammadiHamidreza Mohammadi ORCID7,*
1Division of Toxicology, Department of Comparative Biosciences, University of Tehran, Tehran, Iran
2Research Center for Life and Health Sciences and Biotechnology of the Police, Directorate of Health, Rescue and Treatment, Police Headquarter, Tehran, Iran
3Electrophysiology Research Center, Neuroscience Institute, Tehran, Iran
4Department of Clinical Pharmacy, Razi Herbal Medicine Research Center, Faculty of Pharmacy, Lorestan University of Medical Sciences, Khorramabad, Iran
5Student Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran
6Iranian Cancer Control Center (MACSA), Tehran, Iran
7Department of Toxicology, Razi Herbal Medicine Research Center, Faculty of Pharmacy, Lorestan University of Medical Sciences, Khorramabad, Iran
*Corresponding Author: Department of Toxicology, Razi Herbal Medicine Research Center, Faculty of Pharmacy, Lorestan University of Medical Sciences, Khorramabad, Iran. Email: hamidrezamohammadi65@yahoo.com
Archives of Neuroscience:Vol. 11, issue 1; e141082
Published online:Jun 23, 2024
Article type:Research Article
Received:Oct 15, 2023
Accepted:Dec 20, 2023
How to Cite:Kargar A, Mohammadi F, Amirizadeh M, Hallajbashi N, Kargar F, et al. Retracted: Investigating the Protective Effect of Ellagic Acid on Cholemic Nephropathy in Cholestatic Rats. Arch Neurosci. 2024;11(1):e141082. doi: https://doi.org/10.5812/ans-141082

Dear Readers,
The article titled "Investigating the Protective Effect of Ellagic Acid on Cholemic Nephropathy in Cholestatic Rats" (1), published in the Archives of Neuroscience (link or DOI), is being retracted at the request of the publisher's ethics committee, including the editor-in-chief.
Following a report received from a reader on April 27, 2024 (ticket: #527727), regarding suspected plagiarism involving two main figures (Figures 4 and 5) in the results section of the mentioned article and concerns about the originality of the content, an investigation was conducted involving both the authors and reviewers.
The decision to retract this article was based on clear evidence of plagiarism (unattributed use of large portions of data, presented as figures) and concerns regarding the originality of the content. Specifically, it was found that Figures 4 and 5 in the published article bore a significant resemblance to figures from previously published works in the PharmaNutrition journal (2, 3), constituting a copyright violation:
- Figure 4 was copied from Figure 6 in the article "Hepatoprotective effect of boldine in a bile duct ligated rat model of cholestasis/cirrhosis" (2).
- Figure 5 was copied from Figure 8 in the article "Agmatine Alleviates Hepatic and Renal Injury in a Rat Model of Obstructive Jaundice" (3).
These findings indicate a breach of ethical publishing standards concerning the originality of the data presented. Despite requests for clarification from the authors, a sufficient explanation was not provided within the stipulated time frame.
In accordance with the guidelines provided by the Committee on Publication Ethics (COPE), the decision has been made to retract the article to maintain the integrity of the scientific record [COPE Guidelines on Plagiarism](https://publicationethics.org/resources/flowcharts/plagiarism-published-article).
We apologize to the readers of the journal for any inconvenience caused. The journal remains committed to upholding the highest standards of publication ethics and addressing any issues that arise in a timely and transparent manner.
Sincerely,
Publisher's Ethics Committee (Including the Editor-In-Chief)

References

  • 1.
    Kargar A, Mohammadi F, Amirizadeh M, Hallajbashi N, Kargar F, Mohammadi H. Investigating the Protective Effect of Ellagic Acid on Cholemic Nephropathy in Cholestatic Rats. Arch Neurosci. 2024;11(1). e141082. https://doi.org/10.5812/ans-141082.
  • 2.
    Heidari R, Moezi L, Asadi B, Ommati MM, Azarpira N. Hepatoprotective effect of boldine in a bile duct ligated rat model of cholestasis/cirrhosis. PharmaNutrition. 2017;5(3):109-17. https://doi.org/10.1016/j.phanu.2017.07.001.
  • 3.
    Ommati MM, Farshad O, Mousavi K, Taghavi R, Farajvajari S, Azarpira N, et al. Agmatine alleviates hepatic and renal injury in a rat model of obstructive jaundice. PharmaNutrition. 2020;13:100212. https://doi.org/10.1016/j.phanu.2020.100212.

Copyright

Copyright © 2024, Kargar et al. This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

15
Dec
2018
Corrigendum to: The Effect of Caffeic Acid Phenethyl Ester on Development of Left Ventricular Dysfunction in Cirrhotic Rats [Published in Int Cardiovasc Res J.2016; 10(4).icrj.35598]

Corrigendum to: The Effect of Caffeic Acid Phenethyl Ester on Development of Left Ventricular Dysfunction in Cirrhotic Rats [Published in Int Cardiovasc Res J.2016; 10(4).icrj.35598]

Mahin Dianat,
Samira Saadatfard,
Mohammad Badavi,
Najmeh Sadeghi,
Najmeh Sadeghi
PDF

Dianat M, Saadatfard S, Badavi M, Sadeghi N, Sadeghi N. Corrigendum to: The Effect of Caffeic Acid Phenethyl Ester on Development of Left Ventricular Dysfunction in Cirrhotic Rats [Published in Int Cardiovasc Res J.2016; 10(4).icrj.35598]. Int Cardiovasc Res J. 2018;12(4):e85680. doi:

22
Jan
2024
A Correction to: “Effects of Silymarin and Baicalein on Glycogen Storage in the Hepatocytes of Rat Models of Hepatic Injury,” by Yang et al. (Hepatitis Monthly; 2021; 21(3):e113114)

A Correction to: “Effects of Silymarin and Baicalein on Glycogen Storage in the Hepatocytes of Rat Models of Hepatic Injury,” by Yang et al. (Hepatitis Monthly; 2021; 21(3):e113114)

Seyed Moayed Alavian
PDF

Alavian SM. A Correction to: “Effects of Silymarin and Baicalein on Glycogen Storage in the Hepatocytes of Rat Models of Hepatic Injury,” by Yang et al. (Hepatitis Monthly; 2021; 21(3):e113114). Hepat Mon. 2024;24(1):e145307. doi: https://doi.org/10.5812/hepatmon-145307

10
May
2025

Erratum: Antiproliferative and Apoptotic Effect of Protein Hydrolysates from Lanternfish (Benthosema pterotum) on HT-29 Cell Line of Colorectal Adenocarcinoma [Jundishapur J Nat Pharm Prod. 2025; 20 (1): e149792]

Maryam Shokoohmand,
Hossein Zolgharnein,
Mohammad Ali Salarialiabadi,
Mojtaba Alishahi,
Reza Safari,
Mohammadreza Shushizadeh
,et al.
PDF

Shokoohmand M, Zolgharnein H, Salarialiabadi MA, Alishahi M, Safari R, et al. Erratum: Antiproliferative and Apoptotic Effect of Protein Hydrolysates from Lanternfish (Benthosema pterotum) on HT-29 Cell Line of Colorectal Adenocarcinoma [Jundishapur J Nat Pharm Prod. 2025; 20 (1): e149792]. Jundishapur J Nat Pharm Prod. 2025;20(2):e161340. doi: https://doi.org/10.5812/jjnpp-161340

17
Dec
2018
WITHDRAWN: Histological and Behavioral Alterations Following hADSCs Intravenous Administration in Alzheimer’s Rat Model

WITHDRAWN: Histological and Behavioral Alterations Following hADSCs Intravenous Administration in Alzheimer’s Rat Model

Milad Kazemiha,
Arash Sarveazad,
Fatemeh Moradi,
Marjan Shariatpanahi,
Farnaz Ramezanpour,
Mehran Vosoogh
,et al.
PDF

Kazemiha M, Sarveazad A, Moradi F, Shariatpanahi M, Ramezanpour F, et al. WITHDRAWN: Histological and Behavioral Alterations Following hADSCs Intravenous Administration in Alzheimer’s Rat Model. Thrita J Neu. 2019;8(1):e86288. doi: https://doi.org/10.5812/thrita.86288

17
Sep
2025

Retracted: The Prevalence of Alzheimer’s Disease; its Risk and Protective Factors Among the Elderly Population in Iran [Shiraz E-Med J. 2017; 18 (9): e57576]

Editor-in-Chief IJPBS
PDF

IJPBS E. Retracted: The Prevalence of Alzheimer’s Disease; its Risk and Protective Factors Among the Elderly Population in Iran [Shiraz E-Med J. 2017; 18 (9): e57576]. Shiraz E-Med J. 2025;26(9):e166482. doi: https://doi.org/10.5812/semj-166482

More by these authors

Ali KargarPubMedScholar
Fatemeh MohammadiPubMedScholar
Mehran AmirizadehPubMedScholar
Negin HallajbashiPubMedScholar
Fatemeh KargarPubMedScholar
Hamidreza MohammadiPubMedScholar

Find related work

PubMed
Google Scholar
Create citation alert
Download PDF15.52 MB
Share
Cited by
Metrics
Comments
Number of Comments:0
Indexed in
logoWeb of Sciences Core Collections